Summary
Samenvatting van alle hoorcolleges, werkcolleges en zelfstudies van de cursus Central Nervous System Disorders Thema 1, 2 & 3 (BMW31012)
Deze gedetailleerde samenvatting behandelt alles wat aan bod is gekomen tijdens de hoorcolleges, werkcolleges en zelfstudies van Thema 1, 2 & 3 van de cursus Central Nervous System Disorders aan de Universiteit Utrecht (BMW31012). Hierdoor bevat het alle informatie die nodig is voor het deeltentame...
[Show more]
Preview 4 out of 149 pages
Summarized whole book?
No
Which chapters are summarized?
Unknown
Uploaded on
March 9, 2023
Number of pages
149
Written in
2020/2021
Type
Summary
Book Title: Neuroscience
Author(s): Unknown
Edition: Unknown
ISBN: 9781605358413
Edition: Unknown
Summary
Summary Neurosciences (AB_1200)
Class notes
Summary of Purves Chapter 22: Early Brain Development
Class notes
Samenvatting Fundamentals of Neuroscience, UvA
All for this textbook (44)
Institution
Universiteit Utrecht (UU)
Education
Biomedische Wetenschappen
Course
Central Nervous System Disorders (BMW31012)
All documents for this subject (5)
By: fietjeklopper • 1 year ago
$9.12
100% satisfaction guarantee
Immediately available after payment
Both online and in PDF
No strings attached
Samenvatting Central Nervous
Systems Disorders
Verslaving, neuro-oncologie en stress
Biomedische Wetenschappen
2020-2021
Door Nicole (studente BMW)
,Inhoudsopgave
Klinische aspecten van verslaving ........................................................................................................... 4
Verslavende middelen ......................................................................................................................... 4
Negatieve factoren .......................................................................................................................... 5
Termen ............................................................................................................................................ 6
Geschiedenis ....................................................................................................................................... 6
Bio-psycho-sociale model ................................................................................................................ 6
Diagnostic and Statistical Manual of Mental Disorders (DSM) ........................................................... 7
Screening ............................................................................................................................................. 8
Epidemiologie ...................................................................................................................................... 9
Behandelingen ................................................................................................................................... 11
Detoxificatie .................................................................................................................................. 12
Terugvalpreventie ......................................................................................................................... 13
Neurobiologie van verslaving ................................................................................................................ 14
Primaire hersenregio’s die betrokken zijn bij verslavingen .............................................................. 15
Basale ganglia ................................................................................................................................ 15
Amygdala ....................................................................................................................................... 15
Prefrontale cortex ......................................................................................................................... 16
Verslavingscyclus ............................................................................................................................... 16
Binge/Intoxicatie fase .................................................................................................................... 17
Terugval/Negatief effect ............................................................................................................... 19
Preoccupatie/Anticipatie (verlangen) ........................................................................................... 19
Soorten middelen .............................................................................................................................. 20
Opioïden ........................................................................................................................................ 20
Alcohol ........................................................................................................................................... 21
Stimulerende middelen (stimulants) ............................................................................................. 21
Marihuana (cannabis).................................................................................................................... 21
Synthetische drugs ........................................................................................................................ 21
Van het lab naar de kliniek .................................................................................................................... 22
Synaptische communicatie................................................................................................................ 22
Spike timing-dependent plasticity ................................................................................................. 24
Postsynaptische modificatie .......................................................................................................... 28
Gecombineerde modificatie .......................................................................................................... 32
Verslavingen .................................................................................................................................. 33
Neuro-oncologie .................................................................................................................................... 44
Gliacellen ........................................................................................................................................... 44
1
, Hersentumoren ................................................................................................................................. 45
Hersentumoren bij kinderen ............................................................................................................. 46
Classificatie .................................................................................................................................... 47
Hersentumoren bij volwassen ........................................................................................................... 48
Classificatie .................................................................................................................................... 49
Diagnose ........................................................................................................................................ 50
Behandeling ................................................................................................................................... 50
Mutaties ........................................................................................................................................ 51
Pathways ....................................................................................................................................... 52
Hallmarks ........................................................................................................................................... 57
Niche/micro-omgeving .................................................................................................................. 58
Genetica en pathologie van glioom....................................................................................................... 59
Casus.................................................................................................................................................. 59
Neuro-oncologie ................................................................................................................................ 60
Klinisch beeld................................................................................................................................. 60
Diagnose ........................................................................................................................................ 61
Behandeling ................................................................................................................................... 61
Diffuus glioom ................................................................................................................................... 62
Laaggradige gliomen...................................................................................................................... 64
Hooggradige gliomen .................................................................................................................... 66
Moleculaire classificatie ................................................................................................................ 67
Precision medicine ........................................................................................................................ 69
Epilepsie......................................................................................................................................... 69
Casus.................................................................................................................................................. 70
Glioom: klinische zorg en patiënt casus ................................................................................................ 71
Casus 1 ............................................................................................................................................... 71
Casus 2 ............................................................................................................................................... 72
Casus 3 ............................................................................................................................................... 72
Casus 4 ............................................................................................................................................... 72
Translationeel onderzoek van gliomen ................................................................................................. 75
Translationeel onderzoek .................................................................................................................. 75
Cellijnen ......................................................................................................................................... 75
Glioom-invasie assays........................................................................................................................ 79
Intravital imaging........................................................................................................................... 80
Cerebrale organoïden........................................................................................................................ 81
Tumor-associated microglia (TAM) ............................................................................................... 83
2
, Transcriptomics ................................................................................................................................. 86
Single-cell RNA sequencing ........................................................................................................... 86
Diermodellen voor gliomen................................................................................................................... 90
Neurale stamcellen (NSCs) ................................................................................................................ 90
Neurogenese ................................................................................................................................. 91
Onderzoek ......................................................................................................................................... 92
Gliomen ............................................................................................................................................. 93
Diermodellen ................................................................................................................................. 98
Stress en PTSS...................................................................................................................................... 104
Sympathische zenuwstelsel ......................................................................................................... 104
Parasympathische zenuwstelsel...................................................................................................... 104
Neurobiologie .................................................................................................................................. 105
Hersenstam (locus coeruleus) ..................................................................................................... 105
Hypothalamus & hypofyse (HPA-as) ........................................................................................... 106
Amygdala & prefrontale cortex ................................................................................................... 107
Post-traumatische stress-stoornissen (PTSS) .................................................................................. 108
Neurobiologie .............................................................................................................................. 110
Structurele veranderingen .......................................................................................................... 114
Transcraniële magnetische stimulatie bij depressies .......................................................................... 115
Transcraniële magnetische stimulatie............................................................................................. 116
Neurobiologie van stress-geïnduceerde beloningen .......................................................................... 123
Stress in relatie tot eetgedrag ......................................................................................................... 123
Eetstoornissen ............................................................................................................................. 123
Stress ........................................................................................................................................... 124
Endogene systemen van stressbestendigheid .................................................................................... 134
Neuropeptide Y ............................................................................................................................... 135
Locus coeruleus ........................................................................................................................... 140
3